1. Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014; 9:179. PMID:
25424010.
Article
2. Moghadasian MH. Cerebrotendinous xanthomatosis: clinical course, genotypes and metabolic backgrounds. Clin Invest Med. 2004; 27:42–50. PMID:
15061585.
3. Wang Z, Yuan Y, Zhang W, Zhang Y, Feng L. Cerebrotendinous xanthomatosis with a compound heterozygote mutation and severe polyneuropathy. Neuropathology. 2007; 27:62–66. PMID:
17319284.
Article
4. Pilo B, de Blas G, Sobrido MJ, Navarro C, Grandas F, Barrero FJ, et al. Neurophysiological study in cerebrotendinous xanthomatosis. Muscle Nerve. 2011; 43:531–536. PMID:
21404287.
Article
5. Ginanneschi F, Mignarri A, Mondelli M, Gallus GN, Del Puppo M, Giorgi S, et al. Polyneuropathy in cerebrotendinous xanthomatosis and response to treatment with chenodeoxycholic acid. J Neurol. 2013; 260:268–274. PMID:
22878431.
Article
6. Verrips A, van Engelen BG, ter Laak H, Gabreels-Festen A, Janssen A, Zwarts M, et al. Cerebrotendinous xanthomatosis: controversies about nerve and muscle: observations in ten patients. Neuromuscul Disord. 2000; 10:407–414. PMID:
10899446.
7. Ohnishi A, Yamashita Y, Goto I, Kuroiwa Y, Murakami S, Ikeda M. De- and remyelination and onion bulb in cerebrotendinous xanthomatosis. Acta Neuropathol. 1979; 45:43–45. PMID:
760364.
Article
8. Qrimli M, Ebadi H, Breiner A, Siddiqui H, Alabdali M, Abraham A, et al. Reference values for ultrasonograpy of peripheral nerves. Muscle Nerve. 2016; 53:538–544. PMID:
26316047.
Article
9. Scheidl E, Bohm J, Simo M, Bereznai B, Bereczki D, Aranyi Z. Different patterns of nerve enlargement in polyneuropathy subtypes as detected by ultrasonography. Ultrasound Med Biol. 2014; 40:1138–1145. PMID:
24613217.
Article
10. Won SJ, Kim BJ, Park KS, Yoon JS, Choi H. Reference values for nerve ultrasonography in the upper extremity. Muscle Nerve. 2013; 47:864–871. PMID:
23625758.
Article